Category Archives: The best reads in science and science policy

My picks in Science Policy April 9th-15th

By | April 16, 2017

1. The problems with cancer research cell lines As a cancer biologists, there are several breast cancer cell lines I use every day. Some of these are derived from human tumors, some from mouse tumors that closely mimic what we see in human patients. However, we’ve known for a long time that cell lines don’t… Read More »

My Picks in Science Policy April 1st – 8th

By | April 10, 2017

Why does it matter that the President has no Science Advisor? One of the positions that remains unfilled in the Trump white house is that of science advisor. In this article, Obama’s science advisor, John P. Holdren, goes into what the presidential science advisor does, what the history of the role is, and why the… Read More »

My Picks in Science Policy March 17-24

By | March 26, 2017

  1. What should the role of NASA be going forwards? Federal funding plays a crucial role in high-risk, low-return discoveries. These lay the foundation for future research and industry, fostering economic growth. One of the best examples of this is with the space industry, while NASA conducted the initial research and exploration, it is now… Read More »

The best reads in science/science policy 03/10/-03/17/017

By | March 20, 2017

The big news this week was the release of President Trump’s initial budget plan. If you haven’t taken the chance to take a look at it yet, be sure to read up on its potentially devastating effects, how Republicans in Congress are responding to it, and what happens next. While this is what’s on everybody’s… Read More »

The best reads in science/science policy 03/03/17-03/10/17

By | March 13, 2017

1. Vox explain’s Trump’s FDA pick Trump intends to nominate Scott Gottlieb, a doctor and former FDA deputy commissioner, to head the FDA. As I’ve mentioned before, President Trump aims to shorten drug approval times and cut the FDA’s regulations surrounding drug acceptance, something Gottlieb also supports. It’s not all bad though: Gottlieb wants to… Read More »

The best reads in science/science policy 02/24/17–03/03/17

By | March 7, 2017

1. The deep ties between Patient Groups and Industry One of the last bills passed under President Obama was the 21st Century Cures Act, which was purportedly meant to expand biomedical research and increase the speed by which new drugs reach patients (see my opinion on it here). The drafting of the act was an epic battle… Read More »

The best reads in Science Policy 02/20/17–02/27/17

By | March 7, 2017

1. AAAS stands with the March for Science My own feelings towards the March for Science have been very mixed. I think it’s important for scientists to be active in the name of science, but I worry about tying science to partisanship. Even though the organizers have stated the march is “not about scientists or politicians”, it’s… Read More »